⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Chloropyridine SCHEMBL11389784 | 0.97 | — | — | |
| 2-Chloropyridine SCHEMBL10690176 | 0.97 | TDP1 (1.00) | — | |
| 2-Chloropyridine SCHEMBL28283275 | 0.97 | TDP1 (1.00) | — | |
| 2-Chloropyridine SCHEMBL16637 | 0.97 | — | — | |
| 2-Chloropyridine SCHEMBL29402311 | 0.97 | — | — | |
| 2-Chloropyridine SCHEMBL1935752 | 0.94 | — | — | |
| 2-Chloropyridine SCHEMBL457535 | 0.94 | — | — | |
| 2-Chloropyridine SCHEMBL5751999 | 0.94 | — | — | |
| 2-Chloropyridine SCHEMBL21640063 | 0.94 | — | — | |
| 2-Chloropyridine SCHEMBL30961660 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9394333-B2 | Method for the synthesis of phosphorus atom modified nucleic acids | WAVE LIFE SCIENCES JAPAN (JP) | 2016-07-19 | — | — | US | claimed |
| US-20110294124-A1 | METHOD FOR THE SYNTHESIS OF PHOSPHORUS ATOM MODIFIED NUCLEIC ACIDS | WAVE LIFE SCIENCES LTD. (SG) | 2011-12-01 | — | — | US | claimed |
| EP-2370451-A2 | METHOD FOR THE SYNTHESIS OF PHOSPHORUS ATOM MODIFIED NUCLEIC ACIDS | Chiralgen, Ltd. (JP) | 2011-10-05 | — | — | EP | claimed |
| WO-2010064146-A2 | METHOD FOR THE SYNTHESIS OF PHOSPHORUS ATOM MODIFIED NUCLEIC ACIDS | CHIRALGEN, LTD. (JP) | 2010-06-10 | — | — | WO | claimed |
| US-20240229026-A1 | CHIRAL CONTROL | WAVE LIFE SCIENCES LTD. (SG) | 2024-07-11 | — | — | US | disclosed |
| US-20240175018-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2024-05-30 | — | — | US | disclosed |
| US-20240174710-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | WAVE LIFE SCIENCES LTD. (SG) | 2024-05-30 | — | — | US | disclosed |
| WO-2024108111-A1 | COMPOSITIONS AND METHODS FOR DETECTING UROLOGICAL CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2024-05-23 | — | — | WO | disclosed |
| US-20240150756-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2024-05-09 | — | — | US | disclosed |
| CN-117965536-A | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-20240117347-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2024-04-11 | — | — | US | disclosed |
| US-20240110245-A1 | COMPOSITIONS AND METHODS FOR DETECTING GYNECOLOGICAL CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2024-04-04 | — | — | US | disclosed |
| WO-2010064146-A2 | METHOD FOR THE SYNTHESIS OF PHOSPHORUS ATOM MODIFIED NUCLEIC ACIDS | CHIRALGEN, LTD. (JP) | 2010-06-10 | — | — | WO | disclosed |
| US-20030045698-A1 | Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds | ISIS PHARMACEUTICALS, INC. | 2003-03-06 | — | — | US | disclosed |
| US-6462184-B2 | PROVIDING A PURINE OR PYRIMIDINE BASE CONTAINING NUCLEOSIDE WITH ACID LABILE HYDROXYL PROTECTING GROUP AND A BASE LABILE HYDROXY PROTECTING GROUP SUBSTITUTIONS, DEBLOCKING HYDROXY GROUP, TREATING WITH PHOSPHONATE COMPOUND, CONDENSING AGENT | ISIS PHARMACEUTICALS, INC. | 2002-10-08 | — | — | US | disclosed |
| EP-1159282-A4 | COMPOUNDS, PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF MIXED BACKBONE OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS INC (US) | 2002-08-28 | — | — | EP | disclosed |
| EP-1159282-A1 | COMPOUNDS, PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF MIXED BACKBONE OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2001-12-05 | — | — | EP | disclosed |
| US-20010016652-A1 | Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds | ISIS PHARMACEUTICALS, INC. | 2001-08-23 | — | — | US | disclosed |
| US-6207819-B1 | SYNTHESIZING OLIGONUCLEOTIDE BY DEBLOCKING AND COUPLING NUCLEOTIDES TOGETHER, THEN TREATING WITH OXIDIZING SOLUTION TO CONVERT H-PHOSPHONATE LINKAGES TO PHOSPHODIESTER, PHOSPHOROTHIOATE, PHOSPHORAMIDATE OR BORANOPHOSPHATE | ISIS PHARMACEUTICALS, INC. | 2001-03-27 | — | — | US | disclosed |
| WO-2000047593-A1 | COMPOUNDS, PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF MIXED BACKBONE OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | disclosed |